GAM
BRLI

Gotham Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Gotham Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13,925
Closed -$491K – 1132
2015
Q1 		$491K Buy
13,925
+1,974
+17% +$66.8K ﹤0.01% 701
2014
Q4 		$384K Buy
+11,951
New +$346K ﹤0.01% 783
2014
Q1 		– Sell
-30,507
Closed -$779K – 1155
2013
Q4 		$779K Sell
30,507
-16,817
-36% -$518K 0.02% 676
2013
Q3 		$1.41M Sell
47,324
-8,947
-16% -$249K 0.05% 519
2013
Q2 		$1.62M Buy
+56,271
New +$1.55M 0.07% 416

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Gotham Asset Management's BRLI Position: Q2 2015 in Review

Gotham Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 13,925 shares — an estimated $491K sold.

Gotham Asset Management first reported a position in BRLI in Q2 2013 and held it in 5 quarters. The position peaked at $1.62M in Q2 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • Gotham Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • Gotham Asset Management sold 13,925 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $491K.
  • Gotham Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 5 quarters.
  • Gotham Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $1.62M in Q2 2013.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Gotham Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.